Apollo Hospitals Enterprise Ltd (APOLLOHOSP) Q4FY26 Concall Summary - Mar-2026 Qtr
Performance Overview
- The company reported strong performance in FY26, with consolidated revenues surpassing INR 25,000 crores for the first time, driven by healthy growth across all three verticals: Healthcare Services, Apollo HealthCo, and AHLL.
- The Healthcare Services division demonstrated robust growth, supported by a balanced mix of increased patient volumes, improved case mix, and higher revenue from core specialties like cardiac, oncology, and neurosciences.
- Significant progress was made on the expansion agenda, with four new hospitals operationalized and two more slated for commissioning, which will add approximately 1,400 operating beds in key metro markets.
- The digital health and pharmacy business, Apollo HealthCo, showed significant improvement in operating leverage, with cash losses from the online business declining sharply and the overall segment on track for breakeven.
- A key strategic development was the announced combination of Apollo Cradle & Fertility (part of AHLL) with Cloud 9, creating one of India's largest maternity and fertility care platforms, a move aimed at unlocking value and sharpening focus on primary care and diagnostics.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.